Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 37 results.
User Information
Export Records
  1. 1.   Insight on [1,3]thiazolo[4,5-e]isoindoles as tubulin polymerization inhibitors
  2. Spano, Virginia; Barreca, Marilia; Rocca, Roberta; Bortolozzi, Roberta; Bai, Ruoli; Carbone, Anna; Raimondi, Maria Valeria; Piccionello, Antonio Palumbo; Montalbano, Alessandra; Alcaro, Stefano; Hamel, Ernest; Viola, Giampietro; Barraja, Paola
  3. European Journal of Medicinal Chemistry. 2021, Feb 15; 212
  1. 2.   Regulation of senescence and the SASP by the transcription factor C/EBP beta
  2. Salotti,Jacqueline; Johnson,Peter
  3. Experimental gerontology. 2019, Dec; 128
  1. 3.   Cryptotanshinone has curative dual anti-proliferative and immunotherapeutic effects on mouse Lewis lung carcinoma
  2. Liu, Shuo; Han, Zhen; Trivett,Anna; Lin, Hongsheng; Hannifin,Sean; Yang,De; Oppenheim,Joost
  3. Cancer immunology, immunotherapy : CII. 2019, JUL; 68(7): 1059-1071.
  1. 4.   3 ' UTR elements inhibit Ras-induced C/EBP beta post-translational activation and senescence in tumour cells
  2. Basu, S. K.; Malik, R.; Huggins, C. J.; Lee, S.; Sebastian, T.; Sakchaisri, K.; Quinones, O. A.; Alvord, W. G.; Johnson, P. F.
  3. Embo Journal. 2011, Sep; 30(18): 3714-3728.
  1. 5.   The tumour suppressor C/EBP delta inhibits FBXW7 expression and promotes mammary tumour metastasis
  2. Balamurugan, K.; Wang, J. M.; Tsai, H. H.; Sharan, S.; Anver, M.; Leighty, R.; Sterneck, E.
  3. Embo Journal. 2010, Dec; 29(24): 4106-4117.
  1. 6.   Ras(V12)-Mediated Down-regulation of CCAAT/Enhancer Binding Protein beta in Immortalized Fibroblasts Requires Loss of p19(Arf) and Facilitates Bypass of Oncogene-Induced Senescence
  2. Sebastian, T.; Johnson, P. F.
  3. Cancer Research. 2009 69(6): 2588-2598.
  1. 7.   Recruitment of a SAP18-HDAC1 Complex into HIV-1 Virions and Its Requirement for Viral Replication
  2. Sorin, M.; Cano, J.; Das, S.; Mathew, S.; Wu, X. H.; Davies, K. P.; Shi, X. L.; Cheng, S.; Ott, D.; Kalpana, G. V.
  3. Plos Pathogens. 2009 5(6):
  1. 8.   Mass spectrometric quantification of asparagine synthetase in circulating leukemia cells from acute lymphoblastic leukemia patients
  2. Abbatiello, S. E.; Pan, Y. X.; Zhou, M.; Wayne, A. S.; Veenstra, T. D.; Hunger, S. P.; Kilberg, M. S.; Eyler, J. R.; Richards, N.; Conrads, T. P.
  3. Journal of Proteomics. 2008 71(1): 61-70.
  1. 9.   Genomic profiling of MicroRNA and messenger RNA reveals deregulated MicroRNA expression in prostate cancer
  2. Ambs, S.; Prueitt, R. L.; Yi, M.; Hudson, R. S.; Howe, T. M.; Petrocca, F.; Wallace, T. A.; Liu, C. G.; Volinia, S.; Calin, G. A.; Yfantis, H. G.; Stephens, R. M.; Croce, C. M.
  3. Cancer Research. 2008 68(15): 6162-6170.
  1. 10.   Covalent binding to tubulin by isothiocyanates - A mechanism of cell growth arrest and apoptosis
  2. Mi, L. X.; Xiao, Z.; Hood, B. L.; Dakshanamurthy, S.; Wang, X. T.; Govind, S.; Conrads, T. P.; Veenstra, T. D.; Chung, F. L.
  3. Journal of Biological Chemistry. 2008 283(32): 22136-22146.
  1. 11.   Consistent effects of TSG101 genetic variability on multiple outcomes of exposure to human immunodeficiency virus type 1
  2. Bashirova, A. A.; Bleiber, G.; Qi, Y.; Hutcheson, H.; Yamashita, T.; Johnson, R. C.; Cheng, J.; Alter, G.; Goedert, J. J.; Buchbinder, S.; Hoots, K.; Vlahov, D.; May, M.; Maldarelli, F.; Jacobson, L.; O'Brien, S. J.; Telenti, A.; Carrington, M.
  3. Journal of Virology. 2006, Jul; 80(14): 6757-6763.
  1. 12.   Anti-tumor drug candidate 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole induces single-strand breaks and DNA-protein cross-links in sensitive MCF-7 breast cancer cells
  2. Brantley, E.; Antony, S.; Kohlhagen, G.; Meng, L. H.; Agama, K.; Stinson, S. F.; Sausville, E. A.; Pommier, Y.
  3. Cancer Chemotherapy and Pharmacology. 2006, Jul; 58(1): 62-72.
  1. 13.   CDK2 is required by MYC to induce apoptosis
  2. Deb-Basu, D.; Aleem, E.; Kaldis, P.; Felsher, D. W.
  3. Cell Cycle. 2006, Jun; 5(12): 1342-1347.
  1. 14.   The p270 (ARID1A/SMARCF1) subunit of mammalian SWI/SNF-related complexes is essential for normal cell cycle arrest
  2. Nagl, N. G.; Patsialou, A.; Haines, D. S.; Dallas, P. B.; Beck, G. R.; Moran, E.
  3. Cancer Research. 2005, OCT 15; 65(20): 9236-9244.
  1. 15.   C/EBP beta cooperates with RB : E2F to implement Ras(V12)-induced cellular senescence
  2. Sebastian, T.; Malik, R.; Thomas, S.; Sage, J.; Johnson, P. F.
  3. Embo Journal. 2005, SEP 21; 24(18): 3301-3312.
  1. 16.   HDM2 phosphorylation by MAPKAP kinase 2
  2. Weber, H. O.; Ludwig, R. L.; Morrison, D.; Kotlyarov, A.; Gaestel, M.; Vousden, K. H.
  3. Oncogene. 2005, MAR 17; 24(12): 1965-1972.
  1. 17.   Vpr protein of human immunodeficiency virus type 1 binds to 14-3-3 proteins and facilitates complex formation with Cdc25C: Implications for cell cycle arrest
  2. Kino, T.; Gragerov, A.; Valentin, A.; Tsopanomihalou, M.; Ilyina-Gragerova, G.; Erwin-Cohen, R.; Chrousos, G. P.; Pavlakis, G. N.
  3. Journal of Virology. 2005, MAR; 79(5): 2780-2787.
  1. 18.   Human immunodeficiency virus type 1-induced macrophage gene expression includes the p21 gene, a target for viral regulation
  2. Vazquez, N.; Greenwell-Wild, T.; Marinos, N. J.; Swaim, W. D.; Nares, S.; Ott, D. E.; Schubert, U.; Henklein, P.; Orenstein, J. M.; Sporn, M. B.; Wahl, S. M.
  3. Journal of Virology. 2005 79(7): 4479-4491.
  1. 19.   Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer
  2. Kanao, H.; Enomoto, T.; Ueda, Y.; Fujita, M.; Nakashima, R.; Ueno, Y.; Miyatake, T.; Yoshizaki, T.; Buzard, G. S.; Kimura, T.; Yoshino, K.; Murata, Y.
  3. Cancer Letters. 2004, SEP 15; 213(1): 31-37.
  1. 20.   Regulating the p53 system through ubiquitination
  2. Yang, Y. L.; Li, C. C. H.; Weissman, A. M.
  3. Oncogene. 2004 23(11): 2096-2106.
  1. 21.   Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity
  2. Jansen, A. P.; Camalier, C. E.; Stark, C.; Colburn, N. H.
  3. Molecular Cancer Therapeutics. 2004 3(2): 103-110.
  1. 22.   Partner molecules of accessory protein Vpr of the human immunodeficiency virus type 1
  2. Kino, T.; Pavlakis, G. N.
  3. DNA and Cell Biology. 2004 23(4): 193-205.
  1. 23.   Regulation of HDM2 activity by the ribosomal protein L11
  2. Lohrum, M. A. E.; Ludwig, R. L.; Kubbutat, M. H. G.; Hanlon, M.; Vousden, K. H.
  3. Cancer Cell. 2003 3(6): 577-587.
  1. 24.   Phase I clinical and pharmacokinetic study of flavopiridol administered as a daily 1-hour infusion in patients with advanced neoplasms
  2. Tan, A. R.; Headlee, D.; Messmann, R.; Sausville, E. A.; Arbuck, S. G.; Murgo, A. J.; Melillo, G.; Zhai, S. P.; Figg, W. D.; Swain, S. M.; Senderowicz, A. M.
  3. Journal of Clinical Oncology. 2002 20(19): 4074-4082.
  1. 25.   Human immunodeficiency virus type 1 (HIV-1) accessory protein Vpr induces transcription of the HIV-1 and glucocorticoid- responsive promoters by binding directly to p300/CBP coactivators
  2. Kino, T.; Gragerov, A.; Slobodskaya, O.; Tsopanomichalou, M.; Chrousos, G. P.; Pavlakis, G. N.
  3. Journal of Virology. 2002 76(19): 9724-9734.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel